Distinct radiological features of lymphoepithelioma-like intrahepatic cholangiocarcinoma: comparison with classical intrahepatic cholangiocarcinoma

[11] Nathan H(2021)Checkpoint Inhibition in the Treatment of Unresectable, Advanced Lymphoepithelioma-like Hepatocellular Carcinoma J Clin Transl Hepatol 45 1409-1418

[12] Sotiropoulos GC(2021)Lymphoepithelioma-like Intrahepatic Cholangiocarcinoma Is a Distinct Entity With Frequent pTERT/TP53 Mutations and Comprises 2 Subgroups Based on Epstein-Barr Virus Infection Am J Surg Pathol 72 364-377

[13] Hyder O(2020)Liver resection and transplantation for intrahepatic cholangiocarcinoma J Hepatol 216 393-402

[14] Marques H(2021)The CT and MRI Features of Primary Intrahepatic Lymphoepithelioma-Like Cholangiocarcinoma AJR Am J Roentgenol 30 5337-5347

[15] Pulitano C(2020)Combined hepatocellular-cholangiocarcinoma: which preoperative clinical data and conventional MRI characteristics have value for the prediction of microvascular invasion and clinical significance? Eur Radiol 31 5640-5649

[16] Chan AW(2021)Identifying response in colorectal liver metastases treated with bevacizumab: development of RECIST by combining contrast-enhanced and diffusion-weighted MRI Eur Radiol 290 691-699

[17] Tong JH(2019)Intrahepatic Mass-forming Cholangiocarcinoma: Arterial Enhancement Patterns at MRI and Prognosis Radiology 74 838-849

[18] Sung MY(2021)Clinicopathologic features, tumor immune microenvironment and genomic landscape of Epstein-Barr virus-associated intrahepatic cholangiocarcinoma J Hepatol 38 785-792

[19] Lai PB(2013)Intrahepatic cholangiocarcinoma: relationship between tumor imaging enhancement by measuring attenuation and clinicopathologic characteristics Abdom Imaging 215 89-94

[20] To KF(2000)Perilesional enhancement of hepatic metastases: correlation between MR imaging and histopathologic findings-initial observations Radiology 18 181-188

[11] Nathan H(2021)Checkpoint Inhibition in the Treatment of Unresectable, Advanced Lymphoepithelioma-like Hepatocellular Carcinoma J Clin Transl Hepatol 45 1409-1418

[12] Sotiropoulos GC(2021)Lymphoepithelioma-like Intrahepatic Cholangiocarcinoma Is a Distinct Entity With Frequent pTERT/TP53 Mutations and Comprises 2 Subgroups Based on Epstein-Barr Virus Infection Am J Surg Pathol 72 364-377

[13] Hyder O(2020)Liver resection and transplantation for intrahepatic cholangiocarcinoma J Hepatol 216 393-402

[14] Marques H(2021)The CT and MRI Features of Primary Intrahepatic Lymphoepithelioma-Like Cholangiocarcinoma AJR Am J Roentgenol 30 5337-5347

[15] Pulitano C(2020)Combined hepatocellular-cholangiocarcinoma: which preoperative clinical data and conventional MRI characteristics have value for the prediction of microvascular invasion and clinical significance? Eur Radiol 31 5640-5649

[16] Chan AW(2021)Identifying response in colorectal liver metastases treated with bevacizumab: development of RECIST by combining contrast-enhanced and diffusion-weighted MRI Eur Radiol 290 691-699

[17] Tong JH(2019)Intrahepatic Mass-forming Cholangiocarcinoma: Arterial Enhancement Patterns at MRI and Prognosis Radiology 74 838-849

[18] Sung MY(2021)Clinicopathologic features, tumor immune microenvironment and genomic landscape of Epstein-Barr virus-associated intrahepatic cholangiocarcinoma J Hepatol 38 785-792

[19] Lai PB(2013)Intrahepatic cholangiocarcinoma: relationship between tumor imaging enhancement by measuring attenuation and clinicopathologic characteristics Abdom Imaging 215 89-94

[20] To KF(2000)Perilesional enhancement of hepatic metastases: correlation between MR imaging and histopathologic findings-initial observations Radiology 18 181-188